
Omega Funds
Europe, Geneve, Switzerland, Geneva
Description
Omega Funds global life sciences-based investment firm that specializes in direct secondary transactions.
Investor Profile
Omega Funds has made 148 investments, with 15 in the past 12 months and 22% as lead.
Stage Focus
- Series A (25%)
- Series B (24%)
- Series Unknown (18%)
- Series C (16%)
- Post Ipo Equity (7%)
- Series D (3%)
- Seed (3%)
- Private Equity (1%)
- Series E (1%)
- Post Ipo Debt (1%)
Country Focus
- United States (76%)
- Switzerland (6%)
- United Kingdom (3%)
- France (3%)
- Germany (3%)
- Belgium (3%)
- Canada (1%)
- Israel (1%)
- Spain (1%)
- Denmark (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Health Diagnostics
- Medical Device
- Biopharma
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.